News | September 28, 2021
Zymo Research donates one million Covid-19 test kits to Mapmygenome
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
_256_384.jpg)
Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide
The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Subscribe To Our Newsletter & Stay Updated
